Injectable in situ forming drug delivery system based on poly(ε-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti-cancer evaluation

被引:41
|
作者
Sharifi, Shahriar [1 ,2 ]
Mirzadeh, Hamid [1 ,3 ]
Imani, Mohammad [1 ]
Rong, Zimei [4 ]
Jamshidi, Ahmad [1 ]
Shokrgozar, Mohammadali [5 ]
Atai, Mohammad [1 ]
Roohpour, Nima [4 ]
机构
[1] IPPI, Novel Drug Delivery Syst Dept, Tehran 1497713115, Iran
[2] Amir Kabir Univ Technol, Dept Biomed Engn, Tehran, Iran
[3] Amir Kabir Univ Technol, Dept Polymer Engn, Tehran, Iran
[4] Univ London, IRC Biomed Mat, London E1 4NS, England
[5] Pasteur Inst Iran, Tehran, Iran
关键词
Biocompatibility; Tamoxifen citrate; Photocrosslinking; Poly(caprolactone fumarate); Characterization; DIFFUSION-COEFFICIENT DETERMINATION; TISSUE ENGINEERING APPLICATIONS; DIRECT SIMULATION METHOD; POLY(PROPYLENE FUMARATE); POLY(CAPROLACTONE FUMARATE); UNSATURATED POLYESTERS; DEGRADABLE NETWORKS; CANCER-CHEMOTHERAPY; ANTITUMOR EFFICACY; HYDROGEL FORMATION;
D O I
10.1016/j.actbio.2009.02.004
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The present study deals with the preparation and characterization of an injectable and in situ forming drug delivery system based on photocrosslinked poly(epsilon-caprolactone fumarate) (PCLF) networks loaded with tamoxifen citrate (TC). Networks were made of PCLF macromers, a photoinitiation system (comprising initiator and accelerator) and the active ingredient N-vinyl-2-pyrrolidone (NVP) as a crosslinker and reactive diluent. Shrinkage behavior, equilibrium swelling and sol fraction ratios of photocrosslinked PCLF gels were determined as functions of NVP content. It was shown that the crosslinking is facilitated up to a certain concentration of NVP and most of NVP remained unreacted above this value. In vitro drug release, biocompatibility evaluation and activity against MCF-7 breast cancer cell line were also investigated. Accurate but simple bipartite expressions were also derived that enable rapid determination of effective diffusion coefficients of TC in photocrosslinked PCLF/NVP disks. Cytotoxicity assay showed that while the photocrosslinked PCLF network with optimum NVP content exhibits no significant cytotoxicity against MCF-7 and L929 cell lines, 40-60% of the MCF-7 cells were killed after incubation with TC-loaded devices. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1966 / 1978
页数:13
相关论文
共 50 条
  • [1] Injectable, in situ forming poly(propylene fumarate)-based ocular drug delivery systems
    Ueda, H.
    Hacker, M. C.
    Haesslein, A.
    Jo, S.
    Ammon, D. M.
    Borazjani, R. N.
    Kunzler, J. F.
    Salamone, J. C.
    Mikos, A. G.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2007, 83A (03) : 656 - 666
  • [2] Nanostructure controlled anti-cancer drug delivery using poly(ε-caprolactone) based nanohybrids
    Singh, Narendra K.
    Singh, Sunil K.
    Dash, Debabrata
    Purkayastha, Biswa Pratim Das
    Roy, Jagat K.
    Maiti, Pralay
    JOURNAL OF MATERIALS CHEMISTRY, 2012, 22 (34) : 17853 - 17863
  • [3] Injectable in situ Forming Ocular Drug Delivery System
    Babcock, D. E.
    Burkstrand, M. J.
    Chappa, R. A.
    Hagemeier, C. J.
    Reddy, L. G.
    Slager, J.
    Erickson, S. R.
    Kloke, T. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [4] IN SITU GEL FORMING INJECTABLE DRUG DELIVERY SYSTEM
    Kumbhar, Amruta B.
    Rakde, Ashwini K.
    Chaudhari, P. D.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (02): : 597 - 609
  • [5] In vitro and in vivo drug release from a novel in situ forming drug delivery system
    Kranz, Heiko
    Yilmaz, Erol
    Brazeau, Gayle A.
    Bodmeier, Roland
    PHARMACEUTICAL RESEARCH, 2008, 25 (06) : 1347 - 1354
  • [6] In Vitro and In Vivo Drug Release from a Novel In Situ Forming Drug Delivery System
    Heiko Kranz
    Erol Yilmaz
    Gayle A. Brazeau
    Roland Bodmeier
    Pharmaceutical Research, 2008, 25 : 1347 - 1354
  • [7] Anti-Cancer Drug Delivery System
    Li Yan
    Huang Wei
    Huang Ping
    Zhu Xinyuan
    Yan Deyue
    PROGRESS IN CHEMISTRY, 2014, 26 (08) : 1395 - 1408
  • [8] Injectable In Situ Forming Microparticles: A Novel Drug Delivery System
    Yapar, Evren Algin
    Inal, Ozge
    Ozkan, Yalcin
    Baykara, Tamer
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2012, 11 (02) : 307 - 318
  • [9] Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: Characterization and in vitro evaluation
    Kakinoki, Sachiro
    Taguchi, Tetsushi
    Saito, Hirofumi
    Tanaka, Junzo
    Tateishi, Tetsuya
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (03) : 383 - 390
  • [10] Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer
    Fang, Fang
    Gong, Chang Yang
    Dong, Peng Wei
    Fu, Shao Zhi
    Gu, Ying Chun
    Guo, Gang
    Zhao, Xia
    Wei, Yu Quan
    Qian, Zhi Yong
    BIOMEDICAL MATERIALS, 2009, 4 (02)